Newsroom
May 30, 2025
Expanding the Utility of Donor-Derived Cell-Free DNA and TTV Viral Load Monitoring
At the Cutting Edge of Transplantation 2025 conference, Dr. Steve Kleiboeker, DVM, PhD, spoke about the evolving role of dual-biomarker…
February 13, 2025
TRAC ID: A Clinician’s View on the Next Evolution in Molecular Biomarkers
Dr. John Friedewald, MD, FAST, is a transplant nephrologist and a Professor of Medicine and Surgery at Northwestern University‘s Feinberg…
February 6, 2025
TRAC ID: Transforming Transplant Monitoring With Precision Biomarkers
Dr. Steve Kleiboeker, DVM, PhD, Vice President of Research and Development at Eurofins Transplant Genomic, provides scientific direction and oversight…
November 13, 2024
How OmniGraf Improves Liver Transplant Monitoring
Dr. Steve Kleiboeker, DVM, PhD is the Vice President of Research and Development and Lab Director at Eurofins Transplant Genomics….
November 11, 2024
How Do We Deal With Subclinical Rejection?
Dr. John Friedewald, MD, is a transplant nephrologist and internal medicine doctor who focuses on the care of kidney transplant…
July 17, 2024
Expanding on Molecular Biomarkers in Transplant
Dr. Michael Marvin is Chair of the Department of Transplantation and Liver Surgery at Geisinger Health System and Professor of…
April 1, 2024
Are You In The Know? Biomarker Use In Clinical Settings
Dr. Michael Marvin is the Chair of the Department of Transplantation and Liver Surgery at Geisinger Health System and a…
March 4, 2024
Novel Biomarkers in Kidney Transplant: A Focus on Gene Expression Testing
Preliminary results are available from a study examining gene expression testing as a tool for managing immunosuppression in organ transplant patients….
February 5, 2024
Using Gene Expression Profile Biomarkers as an Immunosuppression Guide in Post-Transplant Care
Dr. John Friedewald serves as Medical Director of Kidney Transplantation at Northwestern Memorial Hospital and is a Professor of Medicine…
December 27, 2023
TRANSPLANT GENOMICS APPROVED AS MEDI-CAL PARTICIPATING PROVIDER
California’s Medicaid grants TGI participating provider status effective June 5, 2023, providing Medi-Cal patients access to non-invasive rejection testing with…